FactSet stock falls over 3% on disappointing guidance

FactSet reported Q4 adjusted EPS of $4.52 versus $4.35 consensus and revenue of $635.5 million versus $629.7 million expected, with revenue up 7.1% year over year. However, fiscal 2027 EPS guidance of $19.25-$19.65, with a $19.45 midpoint, trailed the $19.72 consensus, while revenue guidance midpoint of $2.615 billion was slightly below the $2.62 billion estimate; shares fell 3.45% pre-market. Organic ASV grew 7.0% to $2.57 billion, AI-solution ASV additions more than doubled, and the company returned $179 million through repurchases and dividends.

Analysis

FDS’s setup is now a valuation-versus-execution debate rather than a demand-collapse story. Sub-consensus forward targets leave limited room for a premium information-services multiple to hold unless management can demonstrate that AI products are incremental revenue rather than a retention feature bundled into existing contracts. The more consequential signal is margin: compensation tied to sales growth and technology spend can make incremental subscription revenue less profitable during the product-transition phase, delaying operating leverage for 1-3 quarters.

Competitive read-through is mixed for SPGI, MSCI, MORN and LSEG. FDS’s softer outlook may indicate that buy-side and wealth clients remain selective on new desktop/data spending, but its retention profile suggests displacement risk is contained; this favors scaled incumbents over smaller data vendors dependent on net-new seats. LSEG is the clearest relative beneficiary if clients consolidate data, workflow and AI budgets with broad-platform vendors, while MSCI’s index and analytics mix remains less exposed to discretionary terminal-seat growth.

The contrarian case is that the post-report decline becomes an entry point if AI contract additions convert into disclosed net-new ASV and fiscal-year margins stabilize near the top of the target range. That outcome would re-rate FDS as a credible AI monetizer; however, management has not provided enough AI revenue or pricing detail to underwrite that conclusion today. Near-term downside is most acute if the next quarterly ASV growth rate decelerates or if expense growth again outpaces revenue, forcing another forward-EPS reset.

Key Decisions for Investors

• Maintain a 1-3 month underweight/short bias in FDS versus long MSCI or SPGI; the pair isolates the risk that FDS’s earnings revision cycle lags higher-quality recurring-revenue peers. Cover if FDS reports reaccelerating organic ASV growth and quarterly adjusted margin above 35%.
• Do not add outright FDS exposure on the initial gap down; set an alert for the next earnings release for separately disclosed AI revenue, net-new client wins and ASV growth. Initiate only if those metrics improve without a further reduction in fiscal EPS guidance.
• For existing FDS longs, use any AI-driven rebound before the next quarterly update to reduce exposure or buy downside protection; the key risk is a second guidance reset within 90 days, while upside requires evidence that AI raises ARPU rather than merely protects retention.
• Watch LSEG and MORN for relative strength following FDS’s outlook: a sustained FDS underperformance versus LSEG over the next 4-8 weeks would support a client-budget consolidation thesis and favor long LSEG/short FDS.